title: [Fatal bacteremia related to Capnocytophaga sputigena in a hematological patient with type T non-Hodgkin lymphoma. Diagnosis by 16S rRNA gene sequencing].
abstract: We described a case of fatal bacteremia related to Capnocytophaga sputigena in a hematological patient. The strain was identified by 16S rRNA gene sequencing.
authors.affiliation: Servicio de Análisis Clínicos y Microbiología, Fundación Instituto Valenciano de Oncología, C/Gregorio Gea, 31 (46009) Valencia, España. tglmicro@gmail.com
authors.forename: Tomás
authors.initials: T
authors.lastname: García Lozano
authors.forename: Pablo
authors.initials: P
authors.lastname: Lorente Alegre
authors.forename: María Dolores
authors.initials: MD
authors.lastname: Linares Latorre
authors.forename: Eduardo
authors.initials: E
authors.lastname: Aznar Oroval
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D016470:Bacteremia / Q000150:complications / Q000175:diagnosis / Q000382:microbiology*; D002206:Capnocytophaga / Q000235:genetics / Q000302:isolation & purification*; D016190:Carboplatin / Q000008:administration & dosage / Q000009:adverse effects; D060085:Coinfection; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D004269:DNA, Bacterial / Q000032:analysis* / Q000235:genetics; D004275:DNA, Ribosomal / Q000032:analysis* / Q000235:genetics; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects; D017809:Fatal Outcome; D016905:Gram-Negative Bacterial Infections / Q000150:complications / Q000175:diagnosis / Q000382:microbiology*; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage / Q000009:adverse effects; D016867:Immunocompromised Host; D016399:Lymphoma, T-Cell / Q000150:complications* / Q000188:drug therapy / Q000532:radiotherapy; D008297:Male; D009102:Multiple Organ Failure / Q000209:etiology; D009894:Opportunistic Infections / Q000150:complications / Q000175:diagnosis / Q000382:microbiology*; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects; D012329:RNA, Bacterial / Q000235:genetics*; D012336:RNA, Ribosomal, 16S / Q000235:genetics*; D021521:Ribotyping; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D004269:DNA, Bacterial; D004275:DNA, Ribosomal; D012329:RNA, Bacterial; D012336:RNA, Ribosomal, 16S; D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D016190:Carboplatin; D007069:Ifosfamide; D011241:Prednisone